InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke

Stock Information for InspireMD Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About InspireMD Inc.

InspireMD Reports Second Quarter 2025 Financial Results
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
InspireMD Announces Combined Financings of $58 Million
InspireMD to Announce Second Quarter 2025 Financial Results
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.